Entity

Time filter

Source Type


Gasparyan A.Y.,Dudley Group NHS Foundation Trust | Yessirkepov M.,South-Kazakhstan State Pharmaceutical Academy | Gerasimov A.N.,Stavropol State Agrarian University | Kostyukova E.I.,Stavropol State Agrarian University | And 2 more authors.
Biochemia Medica | Year: 2016

Authorship problems are deep-rooted in the field of science communication. Some of these relate to lack of specific journal instructions. For decades, experts in journal editing and publishing have been exploring the authorship criteria and contributions deserving either co-authorship or acknowledgment. The issue of inconsistencies of listing and abbreviating author names has come to the fore lately. There are reports on the difficulties of figuring out Chinese surnames and given names of South Indians in scholarly articles. However, it seems that problems with correct listing and abbreviating author names are global. This article presents an example of swapping second (father’s) name with surname in a ‘predatory’ journal, where numerous instances of incorrectly identifying and crediting authors passed unnoticed for the journal editors, and no correction has been published. Possible solutions are discussed in relation to identifying author profiles and adjusting editorial policies to the emerging problems. Correcting mistakes with author names post-publication and integrating with the Open Researcher and Contributor ID (ORCID) platform are among them. © Croatian Society of Medical Biochemistry and Laboratory Medicine. Source


Mamykova R.U.,Pedagogical University of Peoples Friendship | Ibragimov T.S.,Southwest Research Institute | Pernebekova R.K.,South-Kazakhstan State Pharmaceutical Academy
Life Science Journal | Year: 2014

The aricle presents the method of describing ontogenesis exemplified by Aervalanata (L.)Juss. The ontogenesis significance is demonstrated in the botanic research. There are techniques of cultivating Aerva lanata (L.) in the conditions of Sothern Kazakhstan, the productibity of raw stock and seeds. In the conditions of Southern Kazakhstan, Aerva lanata finishes the life cycle with fructification, which is a reliable indicator of adaptation to new conditions. The full ontogenesis takes place when the culture accelerates leading to premature ageing (the plant at the motherland is biannual, it is a single annual when cultivated). Aerva lanata yields bundant seeding growth proving its plasticity and successful introduction. Considerating its pharmautical propertices and high value, Aervalanata can be recommended for vast cultivation at foothills in the south of Kazakhstan. Source


Botabayeva R.,Kazakh National Medical University | Shertaeva C.,South-Kazakhstan State Pharmaceutical Academy | Blinova O.,South-Kazakhstan State Pharmaceutical Academy | Datkhayev U.,Kazakh National Medical University | And 3 more authors.
Life Science Journal | Year: 2013

This paper presents the results of marketing studies of drug provision of the Republic of Kazakhstan at the regional level, the example of JSC "Himfarm", located in South Kazakhstan region, Shymkent. To achieve the goal we have performed STEP-analysis, which revealed the social, technological, economic and political factors affecting the development of the regional pharmaceutical market. Source


Gasparyan A.Y.,University of Birmingham | Yessirkepov M.,South-Kazakhstan State Pharmaceutical Academy | Gorin S.V.,International Scientific Researches | Kitas G.D.,University of Birmingham | Kitas G.D.,University of Manchester
Croatian Medical Journal | Year: 2014

The article considers available options to educate science editors in the fast-transforming digital environment. There is no single course or resource that can cover their constantly changing and diversifying educational needs. The involvement in research, writing, and reviewing is important for gaining editing skills, but that is not all. Membership in editorial associations and access to updated scholarly information in the field are mandatory for maintaining editorial credentials. Learned associations offer access to a few widely-recognized periodicals. There are also formal training courses covering issues in science writing and ethical editing, but no high-level evidence data exist to promote any of these. Networking with likeminded specialists within the global and regional editorial associations seems a useful strategy to upgrade editorial skills and resolve problems with the quality control and digitization of scholarly periodicals. Source


Gasparyan A.Y.,University of Birmingham | Ayvazyan L.,Yerevan State Medical University | Yessirkepov M.,South-Kazakhstan State Pharmaceutical Academy | Kitas G.D.,University of Birmingham | Kitas G.D.,University of Manchester
Expert Opinion on Drug Metabolism and Toxicology | Year: 2015

Introduction: Colchicine has been successfully used for the treatment of neutrophilic disorders such as familial Mediterranean fever (FMF), Behçet disease (BD) and gout. There is a growing interest in its cardiovascular effects.Areas covered: A MEDLINE/PubMed search for English articles published from January 1972 to June 2015 was completed using the following terms: therapy, pharmacokinetics, efficiency, side effects, toxicity, heart, colchicine, inflammation, FMF, amyloidosis, BD, gout, cardiovascular disorders, pericarditis, arrhythmias, inflammation, neutrophils, platelets.Expert opinion: By targeting neutrophils, endothelial cells and platelets, inhibiting mitosis, vascular hyperplasia and fibrosis, colchicine improves outcomes of pericarditis, myocardial ischemia and coronary interventions. Studies in neutrophilic rheumatic diseases and cardiovascular disorders demonstrated that oral colchicine at doses of 0.5 - 2.5 mg/daily is useful for treating pericarditis, myocardial ischemia and coronary occlusion. In rheumatic and cardiovascular disorders, therapeutic doses of the drug reduce C-reactive protein to levels below 2 mg/L, prevent myocardial damage and preserve normal values of atrial and ventricular impulse generation. One of the drugs frequent side effects is diarrhea, which is treated by diet modification or temporary discontinuation of the therapy. Certain drugs (macrolides, statins), comorbidities and certain genetic factors increase risk of colchicine toxicity. © 2015 Taylor & Francis. Source

Discover hidden collaborations